Literature DB >> 15226124

Improving topical microbicide applicators for use in resource-poor settings.

Janet G Vail1, Jessica A Cohen, Kimberly L Kelly.   

Abstract

With more than 60 potential microbicides being assessed in preclinical or clinical trials, most attention has been centered on products intended for topical application, with much less research conducted on the applicators that will be used to deliver the microbicides. However, applicator design relates to safety, efficacy, and acceptability. As the foundation for a more systematic approach to evaluating and possibly improving designs for topical microbicide applicators, we conducted a literature review and a series of interviews with microbicide developers, trial investigators, and trial sponsors. Our findings indicate that issues concerning applicator safety, reuse, and cost warrant further investigation.

Mesh:

Substances:

Year:  2004        PMID: 15226124      PMCID: PMC1448402          DOI: 10.2105/ajph.94.7.1089

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  12 in total

1.  Acceptability of a bioadhesive nonoxynol-9 gel delivered by an applicator as a rectal microbicide.

Authors:  M Gross; C L Celum; S R Tabet; C W Kelly; A S Coletti; M A Chesney
Journal:  Sex Transm Dis       Date:  1999-11       Impact factor: 2.830

2.  Distribution of a spermicide containing Nonoxynol-9 in the vaginal canal and the upper female reproductive tract.

Authors:  K T Barnhart; A Stolpen; E S Pretorius; D Malamud
Journal:  Hum Reprod       Date:  2001-06       Impact factor: 6.918

3.  Distribution of topical medication in the human vagina as imaged by magnetic resonance imaging.

Authors:  K Barnhart; E S Pretorius; A Stolpen; D Malamud
Journal:  Fertil Steril       Date:  2001-07       Impact factor: 7.329

4.  Measuring preferences for health care interventions using conjoint analysis: an application to HIV testing.

Authors:  Kathryn A Phillips; Tara Maddala; F Reed Johnson
Journal:  Health Serv Res       Date:  2002-12       Impact factor: 3.402

5.  Patient acceptance of prefilled disposable vaginal applicator.

Authors:  M E LePage; D Brown; J Wells
Journal:  Am J Obstet Gynecol       Date:  1988-04       Impact factor: 8.661

6.  Women's preferences for vaginal antimicrobial contraceptives. IV. Attributes of a formulation that would protect from STD/AIDS.

Authors:  E Hardy; K S de Pádua; M J Osis; A L Jiménez; L J Zaneveld
Journal:  Contraception       Date:  1998-10       Impact factor: 3.375

7.  Women's preferences for vaginal antimicrobial contraceptives. III. Choice of a formulation, applicator, and packaging.

Authors:  E Hardy; A L Jiménez; K S de Pádua; L J Zaneveld
Journal:  Contraception       Date:  1998-10       Impact factor: 3.375

8.  Acceptability and feasibility of Micralax applicators and of methyl cellulose gel placebo for large-scale clinical trials of vaginal microbicides.

Authors:  N Coetzee; K Blanchard; C Ellertson; A A Hoosen; B Friedland
Journal:  AIDS       Date:  2001-09-28       Impact factor: 4.177

9.  Acceptability of formulations and application methods for vaginal microbicides among drug-involved women: results of product trials in three cities.

Authors:  T M Hammett; T H Mason; C L Joanis; S E Foster; P Harmon; R R Robles; H A Finlinson; R Feudo; S Vining-Bethea; G Jeter; K H Mayer; P Doherty-Iddings; G R Seage
Journal:  Sex Transm Dis       Date:  2000-02       Impact factor: 2.830

10.  The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial.

Authors:  Kathleen Morrow; Rochelle Rosen; Linda Richter; Anne Emans; Anna Forbes; Jennifer Day; Neetha Morar; Lisa Maslankowski; Albert T Profy; Cliff Kelly; Salim S Abdool Karim; Kenneth H Mayer
Journal:  J Womens Health (Larchmt)       Date:  2003-09       Impact factor: 2.681

View more
  6 in total

1.  Willingness to use microbicides is affected by the importance of product characteristics, use parameters, and protective properties.

Authors:  Kathleen M Morrow; Joseph L Fava; Rochelle K Rosen; Sara Vargas; Candelaria Barroso; Anna L Christensen; Cynthia Woodsong; Lawrence Severy
Journal:  J Acquir Immune Defic Syndr       Date:  2007-05-01       Impact factor: 3.731

2.  An exploratory, randomized, crossover MRI study of microbicide delivery with the SILCS diaphragm compared to a vaginal applicator.

Authors:  Sara Pentlicky; Mark Rosen; Patricia S Coffey; M Kilbourne-Brook; A Shaunik; Courtney A Schreiber; Kurt Barnhart
Journal:  Contraception       Date:  2012-08-13       Impact factor: 3.375

3.  Measuring adherence by visual inspection of returned empty gel applicators in the CAPRISA 004 microbicide trial.

Authors:  Tanuja N Gengiah; Leila E Mansoor; Michele Upfold; Anushka Naidoo; Nonhlanhla Yende-Zuma; Angela D M Kashuba; Quarraisha Abdool Karim; Salim S Abdool Karim
Journal:  AIDS Behav       Date:  2014-05

4.  Design aspects of vaginal applicators that influence acceptance among target users.

Authors:  Alyssa J Bakke; Toral Zaveri; Molly J Higgins; Gregory R Ziegler; John E Hayes
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

5.  Vaginal washing and lubrication among female sex workers in the Mexico-US border region: implications for the development of vaginal PrEP for HIV prevention.

Authors:  Heather A Pines; Shirley J Semple; Steffanie A Strathdee; Craig W Hendrix; Alicia Harvey-Vera; Pamina M Gorbach; Carlos Magis-Rodríguez; Gustavo Martinez; Thomas L Patterson
Journal:  BMC Public Health       Date:  2018-08-14       Impact factor: 3.295

6.  Deducing Mucosal Pharmacokinetics and Pharmacodynamics of the Anti-HIV Molecule Tenofovir from Measurements in Blood.

Authors:  Sachin Govil; David F Katz
Journal:  Sci Rep       Date:  2019-01-14       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.